Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion

Q Bao, Y Xu, M Ding, P Chen - Hereditas, 2020 - Springer
Background Tuberculosis pleural effusion (TPE) and malignant pleural effusion (MPE) are
very common clinical complications. Considering the totally different prognosis and clinical …

[PDF][PDF] Clinical impact of serum miR-661 in diagnosis and prognosis of non-small cell lung cancer.

GH Zhou, WH Yang, B Sun - European Review for Medical & …, 2017 - europeanreview.org
OBJECTIVE: The aim of this study was to evaluate whether serum miR-661 could serve as a
biomarker for the diagnosis and prognosis of non-small cell lung cancer (NSCLC) …

HIV-1 infection suppresses circulating viral restriction microRNAs

Y Zhou, L Sun, X Wang, H Liang, L Ye… - AIDS research and …, 2016 - liebertpub.com
MicroRNAs (miRNAs) participate in host innate immunity against HIV-1 infection. We
examined the impact of HIV-1 infection on viral restriction miRNAs in plasma of HIV-1 …

DENA: A configurable microarchitecture and design flow for biomedical DNA-based logic design

Z Beiki, A Jahanian - IEEE transactions on biomedical circuits …, 2017 - ieeexplore.ieee.org
DNA is known as the building block for storing the life codes and transferring the genetic
features through the generations. However, it is found that DNA strands can be used for a …

[HTML][HTML] MicroRNA-155 expression in exhaled breath condensate of patients with lung cancer

FK Ibrahim, R Ali-Labib, IH Galal… - Egyptian Journal of Chest …, 2017 - Elsevier
Abstract Background Nowadays, microRNAs (miRNAs) have proved their significant role in
the diagnosis and prognosis of various types of malignancy. Accordingly, this study aimed at …

The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system

M Safavi, R Sabourian, M Abdollahi - Expert Opinion on Drug …, 2016 - Taylor & Francis
Introduction: The task of discovery and development of novel therapeutic agents remains an
expensive, uncertain, time-consuming, competitive, and inefficient enterprise. Due to a …

Liquid profiling in lung cancer–quantification of extracellular miRNAs in bronchial lavage

B Schmidt, G Rehbein, M Fleischhacker - … in Serum and Plasma–CNAPS IX, 2016 - Springer
Extracellular miRNAs cannot only be isolated from different body fluids like plasma and
serum, but also from bronchial lavage samples (BL) obtained by bronchoscopy. Alterations …

OncomicroRNAs-mediated tumorigenesis: implication in cancer diagnosis and targeted therapy

N Zheng, P Yang, Z Wang… - Current Cancer Drug …, 2017 - ingentaconnect.com
MicroRNAs (miRNAs) control the expression of approximately 60% of protein-coding genes
and regulate cell metabolism, proliferation, differentiation, and apoptosis. Notably, aberrant …

[HTML][HTML] 痰液中生物活性物质在肺癌诊断中的作用和意义

金愈茗, 陈子轩, 陈权, 沙雷皓, 沈诚 - Chinese Journal of Lung …, 2021 - ncbi.nlm.nih.gov
肺癌是我国目前发病率最高的恶性肿瘤之一, 其诊断的金标准需要进行组织活检的病理学检查
或脱落细胞学检查, 二者的有创性和敏感性限制了他们的使用。 痰液中含有大量核酸、 蛋白质 …

[引用][C] 疾病相关生物标志物—血清miRNAs 的研究进展

彭梦玲, 杨焕民, 刘艳芝, 计红, 甄莉 - 中国生物制品学杂志, 2015